Sunday, 23 June 2024

News Feed
Most Popular
Pharma News
BioTech News
MedTech News
BioServices News
Video Gallery

Inside Magazine


After two tumultuous years marred by geopolitical tensions and recession, the biotech sector IPOs (initial public offering) is showing signs of recovery. Experts are hopeful that this year will revive the public equity markets for biotech companies. Twelve biotech companies have gone public this year, raising a total of nearly $1.5 billion, compared to a total of only nineteen biotech companies, throughout 2023. Are biotech IPOs poised for an upswing? Is the worst finally over for biotech IPOs? Let's find out.

Click here to access E-magazine

BioSpectrum Infomercial

Automation & High Throughput with SUEZ's Sievers Eclipse BET Platform